Impact of preoperative hemodynamic support on early outcome in patients assisted with paracorporeal Thoratec® ventricular assist device

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 2, 2008, Pages 262-267

  Kirsch, Matthias ^a   Vermes, Emmanuelle ^a   Radu, Costin ^a   Streich, Birgit ^a   Nakashima, Kuniki ^a   Mekontso Dessap, Armand ^a   Loisance, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Adrenaline; Cardiogenic shock; Mechanical circulatory support; Survival

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; MILRINONE; NORADRENALIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; BILIRUBIN BLOOD LEVEL; CARDIOGENIC SHOCK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEVICE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT DURATION;

ADOLESCENT; ADULT; ASSISTED CIRCULATION; EPIDEMIOLOGIC METHODS; EPINEPHRINE; FEMALE; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 46949105691     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.03.057     Document Type: Article

References (26)

1. Loisance D., Pouillart F., Benvenuti C., Deleuze P.H., Mazzucotelli J., Le Besnerais P., and Mourtada A. Mechanical bridge to transplantation: when is too early? When is too late?. Ann Thorac Surg 61 (1996) 388-390
2. Gracin N., Johnson M.R., Spokas D., Allen J., Bartlett L., Piccione W., Parrillo J.E., Costanzo M.R., and Calvin J.E. The use of APACHE II scores to select candidates for left ventricular assist device placement. J Heart Lung Transpl 17 (1998) 1017-1023
3. Rao V., Oz M.C., Flannery M.A., Catanese K.A., Argenziano M., and Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 125 (2003) 855-862
4. Bayram M., De Luca L., Massie M.B., and Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 96 Suppl. (2005) 47G-58G
5. Nieminen M.S., Böhm M., Cowie M.R., Drexler H., Filippatos G.S., Jondeau G., Hasin Y., Lopez-Sendon J., Mebazaa A., Metra M., Rhodes A., and Swedberg K. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. The task force on acute heart failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
6. Houel R., Mazoyer E., Boval B., Kirsch M., Vermes E., Drouet L., and Loisance D.Y. Platelet activation and aggregation profile prolonged external ventricular support. J Thorac Cardiovasc Surg 128 (2004) 197-202
7. Schoenfeld D. Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies. Crit Care Med 10 (2006) 103-104
8. Farrar D.J., and Investigators T.V.A.P. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. J Heart Lung Transpl 13 (1994) 93-101
9. Reinhartz O., Farrar D.J., Hershon J.H., Avery G.J., Haeusslein E.A., and Hill J.D. Importance of preoperative liver function as a predictor of survival in patients supported with thoracic ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg 116 (1998) 633-640
10. McBride L.R., Naunheim K.S., Fiore A.C., Moroney D.A., and Swartz M.T. Clinical experience with 111 Thoratec ventricular assist devices. Ann Thorac Surg 67 (1999) 1233-1239
11. El-Banayosy A., Arusoglu L., Kizner L., Tenderich G., Boethig D., Minami K., and Korfer R. Predictors of survival in patients bridged to transplantation with the Thoratec VAD device: a single-center retrospective study on more than 100 patients. J Heart Lung Transpl 19 (2000) 964-968
12. Arabia F.A., Smith R.G., Rose D.S., Arzouman D.A., Sethi G.K., and Copeland J.G. Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation. ASAIO J 42 (1996) M542-M546
13. Masai T., Sawa Y., Ohtake S., Nishida T., Nishimura M., Fukushima N., Yamaguchi T., and Matsuda H. Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation. Ann Thorac Surg 73 (2002) 549-555
14. Deleuze P., Loisance D.Y., Shiiya N., Wan F., Hillion M., Benvenuti C., Heurtematte Y., and Cachera J. Irreversible drop of systemic vascular resistances in patients implanted with the Jarvik total artificial heart. Int J Artif Org 14 (1991) 286-289
15. Baufreton C., Kirsch M., and Loisance D.Y. Measures to control blood activation during assisted circulation. Ann Thorac Surg 66 (1998) 1837-1844
16. Corry D.C., DeLucia III A., Zhu H., Radcliffe R.R., Brevetti G.R., El-Khatib H., Vance S.J., Moyer B.R., Cotts W.G., and Richenbacher W.E. Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device. ASAIO J 44 (1998) M347-M351
17. Johnson D., and Mayers I. Multiple organ dysfunction syndrome: a narrative review. Can J Anaesth 48 (2001) 502-509
18. Hummel M., Czerlinski S., Friedel N., Liebenthal C., Hasper D., von Baehr R., Hetzer R., and Volk H.D. Interleukin-6 and interleukin-8 concentrations as predictors of outcome in ventricular assist device patients before heart transplantation. Crit Care Med 22 (1994) 448-454
19. Geppert A., Steiner A., Zorn G., Delle-Karth G., Koreny M., Haumer M., Siostrzonek P., Huber K., and Heinz G. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 30 (2002) 1987-1994
20. Geppert A., Dorninger A., Delle-Karth G., Zorn G., Heinz G., and Huber K. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med 34 (2006) 2035-2042
21. Leone M., Vallet B., Teboul J., Mateo J., Bastien O., and Martin C. Survey of the use of catecholamines by French physicians. Int Care Med 30 (2004) 984-988
22. Menon V., Slater J.N., White H.D., Sleeper L.A., Cocke T., and Hochman J.S. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 108 (2000) 374-380
23. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction. Expanding the paradigm. Circulation 107 (2003) 2998-3002
24. Holmes C.L. Vasoactive drugs in the intensive care unit. Curr Opin Crit Care 11 (2005) 413-417
25. Uusaro A., and Russel J.A. Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients?. Int Care Med 26 (2000) 299-304
26. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., Mullany C.J., Ornato J.P., Pearle D.L., Sloan M.A., Smith S.C., Alpert J.S., Anderson J.L., Faxon D.P., Fuster V., Gibbons R.J., Gregoratos G., Halperin J.L., Hiratzka L.F., Hunt S.A., and Jacobs A.K. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 110 (2004) e82-e293